Outcomes After Müller Muscle Conjunctival Resection Versus External Levator Advancement in Severe Involutional Blepharoptosis.

American journal of ophthalmology 2020 Vol.217() p. 182-188

Sweeney AR, Dermarkarian CR, Williams KJ, Allen RC, Yen MT

관련 도메인

Abstract

[PURPOSE] To compare outcomes between Müller muscle conjunctival resection (MMCR) ptosis repair and external levator resection (ELR) in patients with severe involutional blepharoptosis.

[DESIGN] Retrospective, interventional, comparative case series.

[METHODS] A retrospective review was performed of patients who underwent ptosis repair between 2012 and 2019. Inclusion criteria were patients who underwent MMCR or ELR ptosis repair, patients with complete documentation of preoperative eyelid measurements, and patients with documentation of postoperative outcome. The main outcome measure was surgical failure, defined as patient-reported or physician-reported dissatisfaction with postoperative eyelid height or postoperative upper margin reflex distance (MRD1) of less than 2 mm. Severe ptosis was described as an MRD1 of 0 or worse. Outcome analysis was also performed after stratification for concomitant blepharoplasty performed at the time of ptosis repair.

[RESULTS] A total of 231 patients (372 eyelids) met the study criteria, of which 142 eyelids had severe ptosis. Comparing outcomes of MMCR vs ELR in patients with severe ptosis, there was a statistically significant higher rate of success after MMCR (P = .0143). The rate of ptosis repair success in eyelids that underwent MMCR was 97.2% and 90.9% in patients with severe ptosis and mild/moderate ptosis, respectively (P = .42). In eyelids that underwent ELR, the rate of ptosis repair success was 77.4% and 85% in eyelids with severe ptosis and mild/moderate ptosis, respectively (P = .15). Concomitant blepharoplasty did not affect ptosis repair outcomes in any group.

[CONCLUSIONS] MMCR ptosis repair is an effective approach in treating patients with severe ptosis, and it may offer superior outcomes to ELR. In patients with good responses to phenylephrine, MMCR may offer an efficient and highly efficacious surgery regardless of presenting MRD1.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 blepharoplasty 안검성형술 dict 2
해부 eyelid 눈꺼풀 dict 2
해부 Levator scispacy 1
해부 muscle conjunctival scispacy 1
해부 upper margin scispacy 1
해부 eyelids scispacy 1
합병증 involutional scispacy 1
합병증 eyelids scispacy 1
약물 phenylephrine C0031469
phenylephrine
scispacy 1
약물 [DESIGN] scispacy 1
약물 [RESULTS] A scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 Blepharoptosis C0005745
Blepharoptosis
scispacy 1
질환 MMCR) ptosis repair and external levator resection scispacy 1
질환 ptosis repair C0197280
Repair of blepharoptosis
scispacy 1
질환 MMCR → Müller muscle conjunctival resection scispacy 1
질환 ptosis C0005745
Blepharoptosis
scispacy 1
질환 ptosis repair success scispacy 1
질환 mild/moderate ptosis scispacy 1
질환 MMCR ptosis scispacy 1
질환 Muscle Conjunctival scispacy 1
기타 patients scispacy 1
기타 MRD1 scispacy 1
기타 ELR → external levator resection scispacy 1

MeSH Terms

Adult; Aged; Aged, 80 and over; Blepharoplasty; Blepharoptosis; Conjunctiva; Ependymoglial Cells; Eyelids; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oculomotor Muscles; Postoperative Period; Retrospective Studies; Severity of Illness Index; Time Factors; Young Adult

📑 인용 관계

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문